Alexander Ivan Sankin

Alexander Sankin practices at Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein.

Alexander Sankin's NPI, 1982866570, was assigned on June 25, 2008. Alexander Sankin graduated from New York University Grossman School of Medicine in 2008. Alexander Sankin holds New York license 268721.

Alexander Sankin's primary practice is Montefiore Einstein Hospital-Moses Campus, at 111 East 210th Street, Bronx, NY 10467 in Bronx County. The practice phone is (718) 920-4321.

Alexander Sankin's primary practice is Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein. Alexander Sankin is also affiliated with Memorial Sloan Kettering Cancer Center. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Alexander Sankin to 1 more school health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Alexander Sankin practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Alexander Sankin's primary specialty in the NPI Registry, under taxonomy code 208800000X. Alexander Sankin is licensed in New York.

CMS data shows 424 Medicare services from Alexander Sankin across 8 procedure codes in 2024, for 187 Medicare patients. Medicare paid $35,888 for them.

CMS counts 187 Medicare patients who saw Alexander Sankin in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 38% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Alexander Sankin's median patient age at 71, with 25% women.

In 2024, Alexander Sankin wrote 555 Medicare Part D claims for 158 patients. 98% of them were for generic drugs. CMS names the drug for 485 of them, across 5 drugs with 11 or more claims each, at $4,147 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Alexander Sankin for performance year 2024, reported as part of a group. CMS lists Alexander Sankin as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 32 papers to Alexander Sankin, published from 2013 to 2023. 2021 was the busiest year, with 5. The most frequent topics are Kidney Neoplasms, Urinary Bladder Neoplasms and B7-H1 Antigen. Alexander Sankin has published most often in Urol Oncol. Alexander Sankin's most frequent co-authors are Jonathan Andrew Coleman, MD, Ahmed Abdelrahim Mohamed Aboumohamed, MD and Michael Stephen Chevinsky, MD.

Dmand AI links Alexander Sankin to 1 clinical trial.

CMS Open Payments shows 19 general payments to Alexander Sankin from 8 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 73% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,631.

Alexander Sankin graduated from New York University Grossman School of Medicine in 2008.